Overview
Autosomal dominant non-syndromic intellectual disability (also referred to as autosomal dominant mental retardation or ADID) is a group of genetically heterogeneous conditions characterized by significant limitations in intellectual functioning and adaptive behavior that arise during the developmental period, without the additional systemic features or recognizable physical patterns that define syndromic forms of intellectual disability. The condition is caused by heterozygous pathogenic variants in any of numerous genes, with many distinct genetic subtypes identified (designated MRD1 through MRD70+ in OMIM). These genes are involved in critical neurodevelopmental pathways including synaptic signaling, chromatin remodeling, and transcriptional regulation, primarily affecting the central nervous system. The core clinical feature is intellectual disability ranging from mild (ICD-10: F70) to profound (ICD-10: F73), manifesting as delays in cognitive development, speech and language acquisition, learning, and adaptive skills such as social functioning and daily living activities. By definition, the condition is non-syndromic, meaning that affected individuals do not have a consistent pattern of major congenital malformations, distinctive facial features, or multi-organ involvement, although minor or variable associated features such as behavioral difficulties, attention problems, or mild motor delays may sometimes be present. Onset is typically recognized in infancy or early childhood when developmental milestones are not met at expected ages. There is currently no cure or disease-specific pharmacological treatment for autosomal dominant non-syndromic intellectual disability. Management is supportive and multidisciplinary, focusing on early intervention programs, speech and language therapy, occupational therapy, special education services, and behavioral support. Genetic counseling is important for affected families, as the condition follows an autosomal dominant inheritance pattern, meaning each child of an affected individual has a 50% chance of inheriting the causative variant. However, many cases arise from de novo (new) mutations, with no prior family history of the condition.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Autosomal dominant non-syndromic intellectual disability.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal dominant non-syndromic intellectual disability at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Autosomal dominant non-syndromic intellectual disability.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal dominant non-syndromic intellectual disability.
Community
No community posts yet. Be the first to share your experience with Autosomal dominant non-syndromic intellectual disability.
Start the conversation →Latest news about Autosomal dominant non-syndromic intellectual disability
2 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Autosomal dominant non-syndromic intellectual disability
What is Autosomal dominant non-syndromic intellectual disability?
Autosomal dominant non-syndromic intellectual disability (also referred to as autosomal dominant mental retardation or ADID) is a group of genetically heterogeneous conditions characterized by significant limitations in intellectual functioning and adaptive behavior that arise during the developmental period, without the additional systemic features or recognizable physical patterns that define syndromic forms of intellectual disability. The condition is caused by heterozygous pathogenic variants in any of numerous genes, with many distinct genetic subtypes identified (designated MRD1 through
How is Autosomal dominant non-syndromic intellectual disability inherited?
Autosomal dominant non-syndromic intellectual disability follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Autosomal dominant non-syndromic intellectual disability typically begin?
Typical onset of Autosomal dominant non-syndromic intellectual disability is infantile. Age of onset can vary across affected individuals.